<DOC>
	<DOCNO>NCT00624923</DOCNO>
	<brief_summary>The hypothesis western lifestyle , sedentary behavior caloric excess promote chronic , subacute inflammatory state participates development progression atherosclerosis . We evaluate effect target inflammation use anti-inflammatory drug salsalate , compare placebo , coronary artery plaque volume assess multi-detector computed tomographic angiography ( MDCTA ) . The TINSAL-CVD study randomize , double-masked , placebo-controlled , 2 arm , clinical trial . The purpose study compare effect salsalate placebo sub-acute inflammation coronary plaque , people cardiovascular disease . Participants randomize active intervention ( salsalate ) placebo intervention period 30 month . The primary endpoint change plaque volume coronary artery assess MDCTA baseline 30 month .</brief_summary>
	<brief_title>Targeting Inflammation Using Salsalate CardioVascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>Eligibility base upon presence establish coronary artery disease include previous myocardial infarction ( ≥6 month ago ) , previous coronary bypass surgery ( &gt; 12 month ago ) , stable angina , significant noncalcified plaque least one coronary artery , abnormal exercise tolerance test area reversible ischemia nuclear imaging study pharmacologic stress , subsequent revascularization , angioplasty , abnormal exercise treadmill stress test without nuclear image echocardiography follow exclusion : Exclusions base nuclear imaging : 1 . Transient cavity dilation 2 . More one vascular territory involve reversible defect ( multiple defect ) 3 . Reversible defect involve anterior wall , septum apex ( LAD territory ) Exclusions base echocardiography imaging : 1 . More one vascular territory involve inducible wall motion abnormality ( multiple defect ) 2 . Inducible wall motion abnormality involve anterior wall , septum apex ( LAD territory ) Subjects list 6 month myocardial infarction and/or revascularization procedure eligible . In addition , subject must : 1. age 21 75 year inclusive , 2 . BMI ≥ 27 kg/m2 ≤ 35 kg/m2 female ≤ 40 kg/m2 male ( BMI ≥24.5 subject Asian origin ) 3. stable dose HMG CoA reductase inhibitor ( statin ) 1 month screen unable tolerate statin , 4. normal renal function , ( note estimate creatinine clearance calculate use CockcroftGault ( CG ) equation ≥60 screen [ eCrCLCG ( ml/min ) = [ ( 140 age ) x weight ( kg ) ] / [ SCr ( mg/dl ) x 72 ] x [ 0.85 female ] , 5. liver function ( ALT , AST ) &lt; 3 time upper limit normal ) , 6. normal thyroid function ( stable dose replacement therapy acceptable ) , 7. woman child bear potential must pregnancy test prior CT angio use contraception remainder study 8. patient T2D must fast glucose ≤ 200 mg/dl screening treat thiazolidinedione class agent insulin Extendin4 ( Byetta ) therapy . Subjects must willing least three visit Beth IsraelDeaconess Medical Center/Joslin Diabetes Center baseline 30month followup series image study include CT angiography coronary artery image aorta , abdominal adiposity liver , interim visit 1 year . 1 . Unstable angina ( increase frequency severity anginal episode development chest pain rest ) 2. significant obstructive disease ( ≥ 70 % ) leave main coronary artery , ostial LAD threevessel disease MDCTA 3 . Significant heart failure ( NYHA class III IV ) 4 . Current atrial fibrillation WolfParkinsonWhite ( WPW ) syndrome 5 . Allergy betablocker subject rest heart rate &gt; 65 bpm 6 . Systolic blood pressure &gt; 160 mm Hg 7 . Diastolic BP &gt; 100 mm Hg 8 . Persons allergy contrast material 9 . History asthma unable tolerate beta blocker 10 . Allergy iodinate contrast material shellfish 11 . Allergy nitroglycerin 12 . BMI &gt; 35 kg/m2 female &gt; 40 kg/m2 male 13 . Body weight &gt; 350 lbs 14 . Use drug weight loss [ e.g . Xenical ( orlistat ) , Meridia ( sibutramine ) , Acutrim ( phenylpropanolamine ) similar overthe counter medication ] within three month screen 15 . Surgery within 30 day screen 16 . History acquire immune deficiency syndrome human immunodeficiency virus ( HIV ) 17 . Poor mental function history dementia/ Alzheimer 's Disease medication use treatment dementia [ e.g . Tacrine ( Cognex ) , Rivastigmine ( Exelon ) , Galantamine ( Razadyne , Reminyl ) , Donepezil ( Aricept ) , Memantine ( Namenda ) ] reason expect patient difficulty comply requirement study 18 . Medicine erectile dysfunction within 72 hour prior MDCTA 19 . History significant chronic rheumatologic chronic inflammatory disease ( include foot ulcer ) 20 . Prior hemorrhagic stroke 21. person know aspirin allergy 22 . Use continuous oral corticosteroid treatment ( 2 week ) , patient require corticosteroid within 3 month 23 . Antidiabetic medication include thiazolidinedione ( pioglitazone rosiglitazone ) , insulin Extendin4 ( Byetta ) 24 . History peptic ulcer gastritis within 5 year 25 . Positive stool guaiac 26 . Hemoglobin 2 standard deviation normal 27 . Low platelet count ( 2 standard deviation normal ) 28 . Known bleed disorder 29 . Coumadin ( warfarin compound ) 30 . History type 1 diabetes and/or history ketoacidosis 31 . Daily use NSAIDS ( include salsalate ) arthritis 32 . History malignancy , except subject diseasefree great 5 year , whose malignancy basal squamous cell skin carcinoma 33 . History drug alcohol abuse , current weekly alcohol consumption &gt; 14 units/week ( 1 unit = 1 beer , 1 glass wine , 1 mixed cocktail contain 1 ounce alcohol ) 34 . Use probenecid ( Benemid , Probalan ) , sulfinpyrazone ( Anturane ) uricosuric agent 35 . Chronic tinnitus .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Overweight</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Salsalate</keyword>
</DOC>